T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.47B |
| 2 |
NXP Semiconductors
NXPI
|
+$1.73B |
| 3 |
Tesla
TSLA
|
+$1.7B |
| 4 |
Northrop Grumman
NOC
|
+$1.67B |
| 5 |
Dollar Tree
DLTR
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.29B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.85B |
| 3 |
Texas Instruments
TXN
|
+$1.82B |
| 4 |
Microsoft
MSFT
|
+$1.27B |
| 5 |
Booking.com
BKNG
|
+$1.18B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.76% |
| 2 | Technology | 16.79% |
| 3 | Consumer Discretionary | 15.26% |
| 4 | Financials | 14.49% |
| 5 | Industrials | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Compañía de Minas Buenaventura
BVN
$8.66B
| $97.7M | 0.01% |
7,282,732
+533,146
| +8% | +$6.93M |
|
677
WEX
WEX
$6.68B
| $96.5M | 0.01% |
480,924
+507
| +0.1% | +$97.2K |
|
678
American Public Education
APEI
$840M
| $96.1M | 0.01% |
2,908,449
+199,752
| +7% | +$7.65M |
|
679
Domino's
DPZ
$11.5B
| $95.9M | 0.01% |
325,246
-47,186
| -13% | -$13.4M |
|
|
ZNGA
680
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $95.8M | 0.01% |
23,898,860
+493,073
| +2% | +$1.98M |
|
|
FTCH
681
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $95.4M | 0.01% |
+3,503,263
| New | +$99.2M |
|
682
The Ensign Group
ENSG
$10.6B
| $95.4M | 0.01% |
2,688,896
+783,800
| +41% | +$27.3M |
|
|
STFC
683
DELISTED
State Auto Financial Corp
STFC
| $95.3M | 0.01% |
3,120,510
-370,851
| -11% | -$11.6M |
|
684
Glaukos
GKOS
$11.1B
| $95M | 0.01% |
1,464,076
-847,266
| -37% | -$41.6M |
|
685
Glacier Bancorp
GBCI
$6.46B
| $95M | 0.01% |
2,204,178
-92,096
| -4% | -$4.01M |
|
686
Carpenter Technology
CRS
$26.5B
| $94.8M | 0.01% |
1,607,471
-27,922
| -2% | -$1.6M |
|
687
Haemonetics
HAE
$4.16B
| $94.7M | 0.01% |
826,510
+267,321
| +48% | +$27.7M |
|
688
Zebra Technologies
ZBRA
$17.9B
| $94.1M | 0.01% |
531,984
-7,947
| -1% | -$1.27M |
|
|
COBZ
689
DELISTED
CoBiz Financial,Inc
COBZ
| $94.1M | 0.01% |
4,248,335
-233,017
| -5% | -$5.23M |
|
690
Etsy
ETSY
$7.31B
| $93.8M | 0.01% |
1,826,244
-1,473,079
| -45% | -$67.8M |
|
|
ARRY
691
DELISTED
Array Biopharma Inc
ARRY
| $93.5M | 0.01% |
6,151,113
-470,067
| -7% | -$7.2M |
|
692
MKS Inc
MKSI
$21B
| $92.6M | 0.01% |
1,155,660
+202,329
| +21% | +$18.5M |
|
693
Broadridge
BR
$19.2B
| $92.5M | 0.01% |
700,972
-124,281
| -15% | -$15.8M |
|
|
XIFR
694
XPLR Infrastructure LP
XIFR
$1.08B
| $92.4M | 0.01% |
1,904,285
+1,900
| +0.1% | +$90.2K |
|
695
Penumbra
PEN
$12.9B
| $91.9M | 0.01% |
613,880
+32,031
| +6% | +$4.49M |
|
|
BOLD
696
DELISTED
Audentes Therapeutics, Inc
BOLD
| $91.6M | 0.01% |
2,314,604
-21,700
| -0.9% | -$809K |
|
697
Deere & Co
DE
$166B
| $91.5M | 0.01% |
608,562
-10,889
| -2% | -$1.56M |
|
698
Prestige Consumer Healthcare
PBH
$2.44B
| $91.2M | 0.01% |
2,407,914
+398,813
| +20% | +$15.1M |
|
699
Enanta Pharmaceuticals
ENTA
$407M
| $90.9M | 0.01% |
1,063,084
+207,593
| +24% | +$20.8M |
|
|
HTBK
700
DELISTED
Heritage Commerce
HTBK
| $90.3M | 0.01% |
6,051,646
+214,982
| +4% | +$3.4M |
|
Similar funds
T. Rowe Price Associates's Q3 2018 Portfolio in Review
As of Q3 2018, T. Rowe Price Associates held 2,658 positions worth $685B, up 4.7% from $654B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
T. Rowe Price Associates's Q3 2018 filing shows 77 new, 1,268 increased, 1,098 reduced and 77 closed positions. Its largest new stake was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M. The largest sale was Broadcom, an estimated $3.29B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2018 buy was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M.
- T. Rowe Price Associates added most to NVIDIA in Q3 2018, an estimated $2.47B increase.
- T. Rowe Price Associates's biggest Q3 2018 reduction was Broadcom, cutting an estimated $3.29B.
- T. Rowe Price Associates fully exited DCT Industrial Trust Inc. in Q3 2018, selling an estimated $345M.
- T. Rowe Price Associates's ten largest holdings make up 20% of its $685B portfolio in Q3 2018.
- T. Rowe Price Associates opened 77 new positions and closed 77 in Q3 2018.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $685B.
Based on T. Rowe Price Associates's 13F filing for Q3 2018, filed 14 Nov 2018.